Indranill Basu Ray1, Arthur R Menezes2, Pavan Malur2, Aimee E Hiltbold1, John P Reilly3, Carl J Lavie4. 1. Tulane Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA. 2. Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA. 3. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA. 4. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA ; Department of Preventive Medicine, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA ; The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA.
Abstract
BACKGROUND: Chest pain from coronary heart disease (CHD) accounts for more than 8 million emergency department visits every year in the United States, emphasizing the need for cardiovascular (CV) interventions to help reduce this high number. Meditation--a state of contemplation, concentration, and reflection--has the potential to help decrease CV disease. METHODS: This article reviews the available data regarding the effects of meditation on various aspects of CV health. RESULTS: During the past few decades, multiple studies have demonstrated the beneficial effects of meditation on various CV risk factors. In addition to decreasing CV mortality, meditation has also been shown to improve conditions such as hypertension, type 2 diabetes mellitus, dyslipidemia, and high cortisol levels. Still unclear is how current medical therapies impact overall CHD in comparison to meditation techniques. CONCLUSION: Prospective trials are needed to study the effects of meditation on CV risk factors, to provide guidelines for daily meditation practice, and to determine the efficacy of meditation compared to current pharmacologic therapies.
BACKGROUND:Chest pain from coronary heart disease (CHD) accounts for more than 8 million emergency department visits every year in the United States, emphasizing the need for cardiovascular (CV) interventions to help reduce this high number. Meditation--a state of contemplation, concentration, and reflection--has the potential to help decrease CV disease. METHODS: This article reviews the available data regarding the effects of meditation on various aspects of CV health. RESULTS: During the past few decades, multiple studies have demonstrated the beneficial effects of meditation on various CV risk factors. In addition to decreasing CV mortality, meditation has also been shown to improve conditions such as hypertension, type 2 diabetes mellitus, dyslipidemia, and high cortisol levels. Still unclear is how current medical therapies impact overall CHD in comparison to meditation techniques. CONCLUSION: Prospective trials are needed to study the effects of meditation on CV risk factors, to provide guidelines for daily meditation practice, and to determine the efficacy of meditation compared to current pharmacologic therapies.
Authors: Maura Paul-Labrador; Donna Polk; James H Dwyer; Ivan Velasquez; Sanford Nidich; Maxwell Rainforth; Robert Schneider; C Noel Bairey Merz Journal: Arch Intern Med Date: 2006-06-12
Authors: D M Eisenberg; T L Delbanco; C S Berkey; T J Kaptchuk; B Kupelnick; J Kuhl; T C Chalmers Journal: Ann Intern Med Date: 1993-06-15 Impact factor: 25.391
Authors: Robert H Schneider; Clarence E Grim; Maxwell V Rainforth; Theodore Kotchen; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; Jane Morley Kotchen; Charles N Alexander Journal: Circ Cardiovasc Qual Outcomes Date: 2012-11-13
Authors: B G Schwartz; W J French; G S Mayeda; S Burstein; C Economides; A K Bhandari; D S Cannom; R A Kloner Journal: Int J Clin Pract Date: 2012-07 Impact factor: 2.503
Authors: Maxwell V Rainforth; Robert H Schneider; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; James W Anderson Journal: Curr Hypertens Rep Date: 2007-12 Impact factor: 5.369
Authors: Pamela L Thornton; Shiriki K Kumanyika; Edward W Gregg; Maria R Araneta; Monica L Baskin; Marshall H Chin; Carlos J Crespo; Mary de Groot; David O Garcia; Debra Haire-Joshu; Michele Heisler; Felicia Hill-Briggs; Joseph A Ladapo; Nangel M Lindberg; Spero M Manson; David G Marrero; Monica E Peek; Alexandra E Shields; Deborah F Tate; Carol M Mangione Journal: Ann N Y Acad Sci Date: 2019-12-03 Impact factor: 6.499
Authors: Holger Cramer; Helen Hall; Matthew Leach; Jane Frawley; Yan Zhang; Brenda Leung; Jon Adams; Romy Lauche Journal: Sci Rep Date: 2016-11-10 Impact factor: 4.379